ask="17.15"
ask_size="500"
average_daily_volume="743843"
bid="10.50"
bid_size="300"
book_value="9.23"
change="+0.64"
change_from_200_day_moving_average="-12.19"
change_from_50_day_moving_average="0.84"
change_from_52_week_high="-38.59"
change_From_52_week_low="4.93"
change_in_percent="+4.24%"
close="15.73"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.73"
ebitda="-119.41M"
eps_estimate_current_year="-2.82"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-3.28"
ex_dividend_date="N/A"
float_shares="33683000"
high="15.76"
high_52_weeks="54.32"
last_trade_date="1/3/2017"
last_trade_price="15.73"
last_trade_size="38158"
last_trade_time="4:00pm"
low="15.16"
low_52_weeks="10.80"
market_capitalization="680.61M"
moving_average_200_day="27.92"
moving_average_50_day="14.89"
name="Intra-Cellular Therapies Inc."
notes="N/A"
one_year_target_price="35.63"
open="15.36"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-43.66%"
percent_change_from_50_day_moving_average="+5.68%"
percent_change_from_52_week_high="-71.04%"
percent_change_from_52_week_low="+45.65%"
previous_close="15.09"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.64"
price_per_sales="2478.17"
revenue="263466.00"
shares_outstanding="43268000"
short_ratio="6.78"
stock_exchange="NMS"
symbol="ITCI"
volume="410794"
weeks_range_52="10.80 - 54.32"
